These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37964490)

  • 1. The potential blunting effect of metformin and/or statin therapy on physical activity-induced associations with HbA1c in type 2 diabetes.
    Henson J; Davies MJ; Brady EM; Edwardson CL; Hall AP; Khunti K; Redman E; Rowlands AV; Sargeant J; Yates T
    J Diabetes; 2024 Feb; 16(2):e13495. PubMed ID: 37964490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced prevalence of latent tuberculosis infection in diabetes patients using metformin and statins.
    Magee MJ; Salindri AD; Kornfeld H; Singhal A
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30523163
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of Cause-Specific Death in Individuals with Cancer-Modifying Role Diabetes, Statins and Metformin.
    Haukka J; Niskanen L; Auvinen A
    Int J Cancer; 2017 Dec; 141(12):2437-2449. PubMed ID: 28840596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
    Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
    J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of metformin to rescue statin-induced muscle injury and insulin resistance: A proposed mechanism and potential clinical implications.
    Carris NW; Tipparaju SM; Magness DJ; Chapalamadugu KC; Magness RR
    Med Hypotheses; 2017 Sep; 107():39-44. PubMed ID: 28915960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins are Associated With Increased Biochemical Recurrence After Radical Prostatectomy in Diabetic Men but no Association was Seen in Men also Taking Metformin: Results From the SEARCH Database.
    Aminsharifi A; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Polascik TJ; Freedland SJ
    Clin Genitourin Cancer; 2019 Feb; 17(1):e140-e149. PubMed ID: 30366879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pitavastatin improves glycated hemoglobin in patients with poorly controlled type 2 diabetes.
    Huang CH; Huang YY; Hsu BR
    J Diabetes Investig; 2016 Sep; 7(5):769-76. PubMed ID: 27181110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent and joint cross-sectional associations of statin and metformin use with mammographic breast density.
    Lee Argov EJ; Acheampong T; Terry MB; Rodriguez CB; Agovino M; Wei Y; Athilat S; Tehranifar P
    Breast Cancer Res; 2020 Sep; 22(1):99. PubMed ID: 32933550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC; Cull CA; Frighi V; Holman RR
    JAMA; 1999 Jun; 281(21):2005-12. PubMed ID: 10359389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between metformin and physical activity with glucose control in adults with type 2 diabetes.
    Abdalhk D; Riddell MC; Swayze S; Kuk JL
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00206. PubMed ID: 33855209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between baseline characteristics and clinical outcomes in a large population of diabetes patients treated with liraglutide in a real-world setting in Italy.
    Lapolla A; Frison V; Bettio M; Dal Pos M; Rocchini P; Panebianco G; Tadiotto F; Da Tos V; D'Ambrosio M; Marangoni A; Ferrari M; Pianta A; Balzano S; Confortin L; Lamonica M; Marin N; Strazzabosco M; Brun E; Mesturino CA; Simoncini M; Zen F; Bax G; Bonsembiante B; Cardone C; Dal Frà MG; Gallo A; Masin M; Piarulli F; Sartore G; Simioni N
    Clin Ther; 2015 Mar; 37(3):574-84. PubMed ID: 25626486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes.
    Kong AP; Yang X; So WY; Luk A; Ma RC; Ozaki R; Cheung KK; Lee HM; Yu L; Xu G; Chow CC; Chan JC
    BMC Med; 2014 May; 12():76. PubMed ID: 24886453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis.
    Zhou Y; Yuan Y; Cai RR; Huang Y; Xia WQ; Yang Y; Wang P; Wei Q; Wang SH
    Expert Opin Pharmacother; 2013 Aug; 14(12):1575-84. PubMed ID: 23826679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Hemoglobin A1c Levels With Use of Sulfonylureas, Dipeptidyl Peptidase 4 Inhibitors, and Thiazolidinediones in Patients With Type 2 Diabetes Treated With Metformin: Analysis From the Observational Health Data Sciences and Informatics Initiative.
    Vashisht R; Jung K; Schuler A; Banda JM; Park RW; Jin S; Li L; Dudley JT; Johnson KW; Shervey MM; Xu H; Wu Y; Natrajan K; Hripcsak G; Jin P; Van Zandt M; Reckard A; Reich CG; Weaver J; Schuemie MJ; Ryan PB; Callahan A; Shah NH
    JAMA Netw Open; 2018 Aug; 1(4):e181755. PubMed ID: 30646124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes.
    Mu Y; Pan C; Fan B; Hehnke U; Zhang X; Zhang X; Wang X; Liu J; Zhang Y; Du J; Ma J; Gong Y
    Diabetes Res Clin Pract; 2017 Feb; 124():48-56. PubMed ID: 28088030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
    Fadini GP; Frison V; Simioni N; Lapolla A; Gatti A; Bossi AC; Del Buono A; Fornengo P; Gottardo L; Laudato M; Perseghin G; Bonora E; Avogaro A
    J Am Heart Assoc; 2019 Jul; 8(14):e012244. PubMed ID: 31269877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distance to glycemic goal at the time of treatment intensification in patients with type 2 diabetes mellitus failing metformin monotherapy in the United States.
    Fernandes G; Sawhney B; Hannachi H; Liu J; Wang T; Fu AZ; Iglay K; McNeill A; Rajpathak S
    Curr Med Res Opin; 2020 May; 36(5):741-748. PubMed ID: 31990206
    [No Abstract]   [Full Text] [Related]  

  • 19. The Association of Metformin, Other Antidiabetic Medications and Statins on the Prognosis of Rectal Cancer in Patients with Type 2 Diabetes: A Retrospective Cohort Study.
    Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Läärä E; Jukkola A; Karihtala P
    Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin decreases glycated albumin to glycated haemoglobin ratio in patients with newly diagnosed type 2 diabetes.
    Sumitani S; Morita S; Deguchi R; Hirai K; Mukai K; Utsu Y; Miki S; Sato B; Nakamura H; Kasayama S; Koga M
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):76-81. PubMed ID: 24604630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.